About the NTP

Advisory Board & Committees

Actions on Draft Technical Reports Reviewed by the NTP Board of Scientific Counselors Technical Reports Review Subcommittee September 27-28, 2005

Print this page Easy Link

http://ntp.niehs.nih.gov/go/9292

The following DRAFT Technical Reports were reviewed by the NTP Board of Scientific Counselors Technical Reports Review Subcommittee on September 27-28, 2005 (see Federal Register Notice):

Photocarcinogenesis Study of Glycolic acid and Salicylic acid in SKH-1 Mice (Simulated solar light and topical application studies) (TR 524)

The Subcommittee accepted unanimously (6 yes, 0 no) the conclusions as written, no alteration of photocarcinogenesis of simulated solar light by glycolic acid and photoprotection by salicylic acid.

Dibromoacetic acid (TR 537)

The Subcommittee accepted unanimously (6 yes, 0 no) the conclusions as written, some evidence of carcinogenic activity of dibromoacetic acid in male and female F344/N rats, and clear evidence of carcinogenic activity of dibromoacetic acid in male and female B6C3F1 mice. The Subcommittee stated that the increased incidences in mononuclear cell leukemia in male rats may have been related to chemical exposure.

Dichloroacetic acid (GMM 11)

The Subcommittee accepted (5 yes, 1 no) the conclusions as written, no evidence of carcinogenic activity of dichloroacetic acid in p53 haploinsufficient mice.

Bromodichloromethane (GMM 5)

The Subcommittee accepted unanimously (6 yes, 0 no) the conclusions as written, no evidence of carcinogenic activity of bromodichloromethane in p53 haploinsufficient mice.

Sodium bromate (GMM 6)

The Subcommittee accepted unanimously (6 yes, 0 no) the conclusions as written, no evidence of carcinogenic activity of sodium bromate in p53 haploinsufficient mice.

Divinylbenzene (TR 534)

The Subcommittee accepted (5 yes, 0 no, 1 abstention) the conclusions as written, equivocal evidence of carcinogenic activity of divinylbenzene in male F344/N rats and female B6C3F1 mice and no evidence of carcinogenic activity in female F344/N rats and male B6C3F1 mice.

Methyl isobutyl ketone (TR 538)

The Subcommittee accepted unanimously (6 yes, 0 no) the conclusions as written, some evidence of carcinogenic activity of methyl isobutyl ketone in male F344/N rats and in male and female B6C3F1 mice and equivocal evidence of carcinogenic activity in female F344/N rats.

Diisopropylcarbodiimide (TR 523)

The Subcommittee accepted unanimously (5 yes, 0 no) the conclusions as written, no evidence of carcinogenic activity of diisopropylcarbodiimide in male or female F344/N rats or B6C3F1 mice.

Diisopropylcarbodiimide (GMM 10)

The Subcommittee accepted unanimously (5 yes, 0 no) the conclusions as written, no evidence of carcinogenic activity of diisopropylcarbodiimide in p53 haploinsufficient mice.

4-Methylimidazole (TR 535)

The Subcommittee accepted unanimously (5 yes, 0 no) the conclusions as written, no evidence of carcinogenic activity of 4-methylimidazole in male F344/N rats, equivocal evidence of carcinogenic activity in female F344/N rats and clear evidence of carcinogenic activity in male and female B6C3F1 mice.


A limited number of draft reports are available on CD or in printed form and may be requested from Central Data Management (CDM) (email: CDM@niehs.nih.gov).